Lenvatinib, which is an oral multikinase inhibitor, showed non-inferiority to the sorafenib in
terms of overall survival (OS) and a higher objective response rate (ORR) and better …

Background Sarcopenia, characterized by the loss of muscle mass, strength, and physical
ability, occurs with aging and certain chronic illnesses such as chronic liver diseases and …

Although numerous studies have reported the association between sarcopenia and the
prognosis of hepatocellular carcinoma (HCC) patients, there is lack of a newer and more …

Aim To prevent the progression of sarcopenia, early identification is important. We
investigated the usefulness of sarcopenia screening tests using the arm and calf …

Abstract Background and Aim Sarcopenia has received much attention as a poor prognostic
factor in various fields, and has also been reported to worsen prognosis in patients with …

Background Sarcopenia and sarcopenic obesity are associated with an increased possibility
of adverse clinical outcomes; however, the effects of sarcopenia and sarcopenic obesity on …

Simple Summary Although sarcopenia-related factors, including decreased skeletal muscle
index (SMI), have been reported to affect therapeutic efficacy and the occurrence of adverse …

Background/Aim: We aimed to investigate the association between The Geriatric Nutritional
Risk Index (GNRI) and the tolerability of lenvatinib in patients with hepatocellular carcinoma …

Background: Sarcopenia is a prevalent muscle abnormality characterized by progressive
and generalized loss of skeletal muscle mass and strength, common among patients with …

Background Impaired nutritional status is a risk factor for unfavorable outcome in cirrhosis.
Methods In this prospective cohort study in hepatocellular carcinoma patients referred for …